Evaluation of Transient Dyspnea During Gadoxetic Acid Enhanced Multiphasic Liver MRI

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

October 31, 2016

Study Completion Date

February 28, 2018

Conditions
Dyspnea
Interventions
DRUG

gadoxetic acid

standard dose of gadoxetic acid (0.025mmol/kg) intravenous administration

OTHER

Magnetic resonance imaging (MRI)

"Dynamic T1 weighted sequence consist of precontrast, arterial, portal, transitional and hepatobiliary phases.~precontrast, arterial and portal phases (prior to contrast media injection to 60 seconds after contrast media injection) are obtained continuously in free-breathing state. Transitional and hepatobiliary phases are obtained in breath-hold state."

Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Bayer

INDUSTRY

lead

Seoul National University Hospital

OTHER